Skip to main content
Patrick Griffin, MD, Oncology, Fort Worth, TX, Texas Health Harris Methodist Hospital Southwest Fort Worth

PatrickThomasGriffinMD

Oncology Fort Worth, TX

Hematologic Oncology

Hematology and Medical Oncology

Dr. Griffin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Griffin's full profile

Already have an account?

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2013 - 2016
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Internal Medicine, 2010 - 2013
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2010

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Abstract Achievement Award American Society of Hematology 56th Annual Meeting, 2014
  • Doctor's Dilemma Champion Texas Chapter of the American College of Physicians Annual Meeting, 2012
  • Abstract Achievement Award American Society of Hematology 53th Annual Meeting, 2011
  • Join now to see all

Publications & Presentations

PubMed

Books/Book Chapters

Abstracts/Posters

  • Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, Retrospective Analysis
    Griffin PT, Chavez JC, Bello CM, et al., American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
  • Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index
    Griffin PT, Dalia S, Shah BD, et al., American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
  • Is There a Preferred Infusional Regimen for Patients with Relapsed/Refractory Multiple Myeloma?
    Griffin PT, Ho VQ, Fulp W, et al, American Society of Hematology 56th Annual Meeting, San Francisco, CA, 12/2014
  • Join now to see all

Press Mentions

  • In Brief: Medline Acquisition, BOC Honor, Brightree Integration
    In Brief: Medline Acquisition, BOC Honor, Brightree IntegrationMay 21st, 2021

Professional Memberships

Hospital Affiliations